PlainPharmaWatch

CMS Open Payments · Program Year 2024

Granata Bio Corporation

Granata Bio Corporation reported $5,493.03 in payments to 22 physicians and teaching hospitals across 22 transactions.

See the rankings → How this is sourced
$5.5K
Total payments
22
Transactions
22
Recipients
#1703
of 1,925 companies

Granata Bio Corporation reported $5,493.03 in payments to 22 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1703 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $249.68 per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Granata Bio Corporation pairs modest payment volume with a moderately concentrated payment pattern.

#1703
of 1,925 companies
0.0%
of all US industry payments
0.5%
paid to its single top recipient
3
payment categories

How Granata Bio Corporation ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Granata Bio Corporation's total vs. every reporting company

CMS Open Payments, Program Year 2024

$5,493 12th percentile higher than 12% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). This entry sits in this band. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Granata Bio Corporation

$5,493.03: that is what Granata Bio Corporation reported in payments to 22 physicians and teaching hospitals during Program Year 2024, spread across 22 transactions ($249.68 per transaction, $249.68 per recipient). The company sits at rank #1703 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Consulting Fee" leads the 3-category general-payment breakdown below at $3.0K (54.6% of the company's reported total, 1 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Consulting Fee" leads Granata Bio Corporation's 3-category general-payment breakdown at $3.0K, 54.6% of the reported total.

How Granata Bio Corporation divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$3.0K2. Food and Beverage$1.4K3. Travel and Lodging$1.1K
Payment Type Amount Transactions
Consulting Fee $3.0K 1
Food and Beverage $1.4K 19
Travel and Lodging $1.1K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $4,522.19 (82.3%) of $5,493.03 in this company's General Payments records across 19 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Granata Bio Corporation

The five named recipients with the highest reported General Payments from this company

Pietro Bortoletto$3.0KKarina Stroker$1.1KPeter Lindner$153.64Ariel Dunn$153.64Alexandra Poch$102.98
  1. 1

    Pietro Bortoletto

    $3,000.00 across 1 reported transactions

  2. 2

    Karina Stroker

    $1,111.93 across 2 reported transactions

  3. 3

    Peter Lindner

    $153.64 across 2 reported transactions

  4. 4

    Ariel Dunn

    $153.64 across 2 reported transactions

  5. 5

    Alexandra Poch

    $102.98 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $249.68. Average per recipient: $249.68.

Total Amount

$5,493.03

Avg per Transaction

$249.68

Avg per Recipient

$249.68

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Granata Bio Corporation Share

0.0%

#1703 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Granata Bio Corporation

Aquestive Therapeutics, Inc.

$5.5K 214 recipients

Karl Storz Endovision, Inc.

$5.5K 3 recipients

Rare Disease Therapeutics, Inc.

$5.6K 104 recipients

Bridge to Life Ltd

$5.6K 9 recipients

ASD Specialty Healthcare, LLC

$5.3K 60 recipients

Canon Healthcare USA, Inc.

$5.3K 15 recipients

Frequently Asked Questions

How much did Granata Bio Corporation pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $5,493.03 from Granata Bio Corporation to physicians and hospitals across 22 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Granata Bio Corporation? ▾
Granata Bio Corporation made payments to 22 physicians and teaching hospitals in 2024. The average payment per recipient was $249.68.
What types of payments did Granata Bio Corporation make? ▾
General payments from Granata Bio Corporation span 3 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Consulting Fee" at $3.0K, representing 54.6% of the company's reported total.
How does Granata Bio Corporation rank among pharmaceutical companies? ▾
Granata Bio Corporation ranks #1703 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Granata Bio Corporation? ▾
Granata Bio Corporation's 22 transactions to 22 recipients in 2024 averaged $249.68 per transaction.
Where does the payment data for Granata Bio Corporation come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Granata Bio Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.